Bayer CropScience jumped 4.92% to Rs 1,738 at 10:23 IST on BSE after the company said its board will consider share buyback on 22 July 2013.
The company made the announcement after market hours on Thursday, 18 July 2013.
Meanwhile, the S&P BSE Sensex was up 95.08 points, or 0.47%, to 20,223.49.
On BSE, 12,036 shares were traded in the counter as against an average daily volume of 5,073 shares in the past one quarter.
The stock hit a high of Rs 1,769 so far during the day, which is also a record high for the counter. The stock hit a low of Rs 1,705.10 so far during the day. The stock had hit a 52-week low of Rs 765.05 on 25 July 2012.
The stock had outperformed the market over the past one month till 18 July 2013, rising 17.49% compared with the Sensex's 4.71% rise. The scrip had outperformed the market in past one quarter, soaring 49.22% as against Sensex's 5.85% rise.
The mid-cap company has an equity capital of Rs 39.50 crore. Face value per share is Rs 10.
Bayer CropScience said its board will meet on 22 July 2013 to consider a proposal to buyback the company's equity shares. The board will also consider constituting a buyback committee.
Bayer CropScience reported net profit of Rs 71.80 crore in Q4 March 2013 as against net loss of Rs 21.60 crore in Q4 March 2012. Net sales rose 55.68% to Rs 367.40 crore in Q4 March 2013 over Q4 March 2012.
Bayer CropScience is one of the world's leading crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers a range of products and backup for modern, sustainable agriculture and for non-agricultural applications.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
